Current Advances in Treatment and Recommendations for Evaluation and Rehabilitation
This two-day course is provided to first, teach healthcare providers on the clinical perspective of spinal muscular atrophy (SMA) including the broad phenotypic spectrum of pediatric and adult patients, evidence of natural history of the disease, new updates to standards of care, clinical outcome measures/standardized assessments, and the influence of therapies both approved and in development; and second, to support healthcare providers, outside of specialized SMA centers, to manage rehabilitation programs and evaluate patient progress using validated standardized clinical assessments in SMA.
When/Where
December 6 – 7, 2019
Li Ka Shing Center for Learning & Knowledge
Stanford University
Stanford, CA
Target Audience
This is an international program designed for physicians, nurses, advance practice nurses (APNs), professional nurses (RNs) physician assistants, physical therapists, administrators, researchers, social workers, allied health professionals, occupational therapists, speech language pathologists, residents, fellows and medical students specializing in Neurology, Pediatrics, and Neuromuscular Specialties.
Learning Objectives
At the conclusion of this activity, participants should be able to:
• Summarize the clinical perspectives of Spinal Muscular Atrophy including disease pathology, phenotypic spectrum, and evidence of natural history.
• Choose and organize suitable rehabilitation programs based on available standards of care recommendations.
• Determine and apply appropriate clinical outcome measures based on age and function with correct administration and scoring of motor performance using these common Spinal Muscular Atrophy measures.
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.